Lates News

Every AI Express, Pacific Securities released a research report on September 9th, giving AnTu Biosciences (603658.SH) a buy rating. The reasons for the rating include: 1) rapid installation of chemiluminescence equipment to offset some negative impacts on the industry; 2) new products gradually landing, expected to boost performance growth; 3) stable trends in gross profit margin and expense ratio. (Daily Economic News)